R. Schaffner
Impact in
- Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Cognitive Neuroscience top 2%
- Memory and Neural Mechanisms
- Sleep and Wakefulness Research
Papers in
-
- Neuroscience and Neuropharmacology Research 10
- Neurotransmitter Receptor Influence on Behavior 5
-
- Healthcare and Venom Research 2
R. Schaffner
19 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Cellular and Molecular Neuroscience 1.9k
- Cognitive Neuroscience 710
- Anesthesiology and Pain Medicine 176
- Psychiatry and Mental health 345
- Behavioral Neuroscience 70
Countries citing papers authored by R. Schaffner
This map shows the geographic impact of R. Schaffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Schaffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Schaffner more than expected).
Fields of papers citing papers by R. Schaffner
This network shows the impact of papers produced by R. Schaffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Schaffner. The network helps show where R. Schaffner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Schaffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 12 | |
| 2 | Pharmacology of moclobemide. | 1993 | 32 |
| 3 | 1989 | 10 | |
| 4 | 1988 | 82 | |
| 5 | 1988 | 74 | |
| 6 | 1987 | 41 | |
| 7 | Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine. | 1982 | 12 |
| 8 | Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT. | 1982 | 9 |
| 9 | 1982 | 301 | |
| 10 | 1982 | 265 | |
| 11 | Pharmacology of midazolam. | 1981 | 127 |
| 12 | Selective antagonists of benzodiazepines Hit paper breakdown → | 1981 | 1070 |
| 13 | 1979 | 2 | |
| 14 | 1978 | 294 | |
| 15 | 1978 | 30 | |
| 16 | Interaction of psychotropic agents with central neurotransmitters as revealed by their effects on PGO waves in the cat. | 1976 | 24 |
| 17 | 1976 | 100 | |
| 18 | 1976 | 11 | |
| 19 | Possible involvement of GABA in the central actions of benzodiazepines. | 1975 | 302 |
About R. Schaffner
R. Schaffner is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Cognitive Neuroscience, Neurology and Anesthesiology and Pain Medicine, having authored 19 papers that have together received 2.8k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Memory and Neural Mechanisms (3 papers), Hormonal and reproductive studies (2 papers), Pain Mechanisms and Treatments (2 papers), Healthcare and Venom Research (2 papers), GABA and Rice Research (2 papers) and Photochromic and Fluorescence Chemistry (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.9k citations), Cognitive Neuroscience (710 citations), Anesthesiology and Pain Medicine (176 citations), Psychiatry and Mental health (345 citations) and Behavioral Neuroscience (70 citations). R. Schaffner has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include W. Haefely, L. Pieri, E. P. Bonetti, P. Polc, R. Cumin, H. Möhler, Walter Hunkeler, G Belcher, R. W. Ryall and Petar Polc. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Nature, Journal of Pharmacology and Experimental Therapeutics, Pain and Pharmacopsychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.